• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Gabriela Perez Joins Big Health as Chief Commercial Officer

    2/3/22 8:00:00 AM ET
    $LH
    $TDOC
    Medical Specialities
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $LH alert in real time by email

    After spending two decades successfully scaling multiple healthcare technology companies, Perez joins Big Health to accelerate the commercial coverage and reimbursement for digital therapeutics

    Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. In her new role, Perez will oversee Big Health's global commercial growth and strategy, including sales, client management, strategic partnerships, and new markets.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220203005297/en/

    Big Health Chief Commercial Officer Gabriela Perez (Photo: Business Wire)

    Big Health Chief Commercial Officer Gabriela Perez (Photo: Business Wire)

    Perez has spent the past two decades building and scaling several technology-enabled healthcare services companies. Most recently, she was Executive Vice President & General Manager at Ovia Health, the largest women & family digital health company in the United States, where she led the company to triple digit year-over-year revenue growth while overseeing more than 2,000 clients and signing 27 new regional and national health plan partnerships. Ovia Health was acquired by Labcorp (NYSE:LH) in August 2021.

    Her entrepreneurial career began as part of the founding team of Best Doctors, a telehealth company that pioneered e-second opinions globally. During her tenure at Best Doctors, Perez held multiple leadership positions across product, marketing, partnerships, and global sales divisions. She was responsible for scaling business units across 45 countries, accounting for hundreds of millions of dollars in revenue. Best Doctors was acquired by Teladoc Health (NYSE:TDOC) in June 2017.

    "Over the past two decades, Gabriela has proven her exceptional ability to drive rapid growth for innovative healthcare companies," said Big Health Co-Founder and CEO Peter Hames. "But what sets Gabriela apart is her humility and mission-driven mentality. This unique combination makes her a perfect fit for Big Health, and we cannot be more excited to welcome her to the team as we continue to accelerate our growth in pursuit of helping millions back to good mental health."

    Big Health is the most scaled digital therapeutics company with the most studied products, including over 10 million covered lives globally, 13 randomized controlled trials evaluating its approach, and more than 28,000 participants across all clinical evidence studies. Sleepio and Daylight¹, Big Health's digital therapeutics for insomnia and anxiety, offer fully automated products that deliver evidence-based mental health care, including cognitive behavioral therapy, without intervention from coaches or clinicians. Through robust clinical evaluation, Big Health's digital therapeutics are proven first-line treatments for mental health care.

    "Over the course of my career in healthcare technology, I have identified three key trends that are paramount to the success of a business: focus on clinical and evidence-based care, purposeful design and engagement, and innovative commercial models," said Perez. "Big Health is leading the digital therapeutics industry in all three areas, and is poised for even faster growth ahead. I cannot be more excited to join Peter and the entire Big Health team to advance our mission of helping millions back to good mental health."

    This key addition follows two momentous announcements for Big Health. In January 2022, Big Health announced a $75 million Series C funding, led by SoftBank Vision Fund 2. The company also announced that it added former Food and Drug Administration (FDA) Deputy Commissioner for Medical and Scientific Affairs Dr. Anand Shah to its Board of Directors to bolster the company's clinical and public policy strategies.

    About Big Health

    Big Health's mission is to help millions back to good mental health by providing safe and effective non-drug alternatives for the most common mental health conditions including insomnia and anxiety. Designed by leading clinical experts, Big Health's digital therapeutics expand access to gold standard care, including behavioral medicine, and are backed by industry-leading research and randomized controlled trials. By seamlessly integrating across the care pathway, from member engagement to billing via pharmacy benefit managers, Big Health simplifies adoption for both payers and patients, providing an inclusive, scalable, and affordable approach without serious side effects. For more information, please visit www.bighealth.com or follow Big Health on LinkedIn and Twitter.

    ¹ In accordance with FDA's Current Enforcement Discretion Policy for Digital Health Devices for Psychiatric Disorders, for patients aged 18 years and older, who are followed by and diagnosed with Insomnia Disorder or Generalized Anxiety Disorder by a medical provider, Sleepio and Daylight can be made available as an adjunct to their usual medical care for Insomnia Disorder or Generalized Anxiety Disorder, respectively. Sleepio and Daylight do not replace the care of a medical provider or the patient's medication. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for these indications.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005297/en/

    Get the next $LH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $LH
    $TDOC

    CompanyDatePrice TargetRatingAnalyst
    Labcorp Holdings Inc.
    $LH
    4/2/2025$276.00Buy
    Redburn Atlantic
    Labcorp Holdings Inc.
    $LH
    3/4/2025$250.00 → $300.00Neutral → Buy
    Citigroup
    Labcorp Holdings Inc.
    $LH
    1/7/2025$260.00 → $265.00In-line → Outperform
    Evercore ISI
    Labcorp Holdings Inc.
    $LH
    12/10/2024$265.00 → $275.00Buy
    Jefferies
    Teladoc Health Inc.
    $TDOC
    11/15/2024$14.00Buy
    Goldman
    Labcorp Holdings Inc.
    $LH
    10/30/2024Hold → Buy
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    10/1/2024$235.00Neutral
    Piper Sandler
    Teladoc Health Inc.
    $TDOC
    9/17/2024$8.00 → $10.00Hold
    Jefferies
    More analyst ratings

    $LH
    $TDOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mckinley Thomas bought $30,756 worth of shares (4,000 units at $7.69), increasing direct ownership by 11% to 39,077 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      9/13/24 5:14:02 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Director Smith Mark Douglas bought $28,312 worth of shares (4,000 units at $7.08), increasing direct ownership by 92% to 8,355 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      8/19/24 4:10:41 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Director Mckinley Thomas bought $81,746 worth of shares (11,000 units at $7.43), increasing direct ownership by 46% to 35,077 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      8/8/24 5:49:44 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $LH
    $TDOC
    SEC Filings

    See more
    • Labcorp Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - LABCORP HOLDINGS INC. (0000920148) (Filer)

      6/27/25 4:16:25 PM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - LABCORP HOLDINGS INC. (0000920148) (Filer)

      6/26/25 4:12:43 PM ET
      $LH
      Medical Specialities
      Health Care
    • SEC Form 144 filed by Labcorp Holdings Inc.

      144 - LABCORP HOLDINGS INC. (0000920148) (Subject)

      6/11/25 4:29:47 PM ET
      $LH
      Medical Specialities
      Health Care

    $LH
    $TDOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Teladoc Health Inc.

      SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

      9/5/24 4:36:22 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Teladoc Health Inc.

      SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

      7/8/24 4:32:41 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

      SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

      2/13/24 5:16:08 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $LH
    $TDOC
    Leadership Updates

    Live Leadership Updates

    See more
    • SOLVD Health Appoints Mike Aicher and Vince Cebula to Board of Directors to Support Next Phase of Growth

      SOLVD Health (SOLVD), a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has appointed diagnostics pioneer Mike Aicher and strategic advisor Vince Cebula to its Board of Directors. Their combined leadership in molecular diagnostics, healthcare technology, and growth-stage investment will support the company's continued expansion as it scales access to personalized health insights and accelerates development of its precision diagnostics platform. Aicher's expertise in building and scaling diagnostic platforms will be instrumental as SOLVD Health expands its personalized health solutions. He brings more than three decades of executiv

      5/12/25 9:00:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp CFO Glenn Eisenberg Announces Plans to Retire

      Julia Wang Named Chief Financial Officer Beginning December 2, 2024 BURLINGTON, N.C., Nov. 19, 2024 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg will retire from the company and Julia Wang will join on December 2, 2024, as Executive Vice President and Chief Financial Officer. Mr. Eisenberg will remain at Labcorp as Special Advisor to the CEO through April 2025 to ensure a seamless transition of his current role and assist with strategic initiatives underway within the company.

      11/19/24 7:00:00 AM ET
      $BGNE
      $LH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical Specialities
    • Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors

      Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board Masimo Corporation (NASDAQ:MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the "Board"), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, "We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals who will bring critical perspectives to the Board and possess expertise that closely aligns

      10/18/24 9:00:00 AM ET
      $ENV
      $LH
      $MASI
      $MSCI
      Business Services
      Consumer Discretionary
      Medical Specialities
      Health Care

    $LH
    $TDOC
    Financials

    Live finance-specific insights

    See more
    • Labcorp to Announce Second Quarter Financial Results on July 24, 2025

      BURLINGTON, N.C., June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The call will be webcast live on the Labcorp Investor Relations website. Participan

      6/26/25 4:10:00 PM ET
      $LH
      Medical Specialities
      Health Care
    • Teladoc Health Reports First Quarter 2025 Results

      PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 ("First Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 ("First Quarter 2024"). First Quarter 2025 Highlights First Quarter 2025 revenue of $629.4 million, down 3% year-over-yearFirst Quarter 2025 net loss of $93.0 million, or $0.53 per share, including a pre-tax goodwill impairment charge of $59.1 million, or $0.34 per share, which occurred after the issuance of the previously provided outlook and was not included First Qu

      4/30/25 4:05:56 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits

      PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.    The acquisition supports the company's strategy to further enhance its leadership position in virtual mental health, including the ability for consumers served by its BetterHelp segment to access benefits coverage for mental health services. UpLift serves the health plan market and has arrangements covering over 100 million lives, a network of over 1,500 mental health professionals, important capabilities and a talent

      4/30/25 4:01:27 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care

    $LH
    $TDOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Anderson Kerrii B sold $132,500 worth of shares (500 units at $265.00), decreasing direct ownership by 4% to 12,166 units (SEC Form 4)

      4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

      7/2/25 10:37:22 AM ET
      $LH
      Medical Specialities
      Health Care
    • Director Evans Jason Eric converted options into 1,016 shares, increasing direct ownership by 17% to 7,113 units (SEC Form 4)

      4 - Teladoc Health, Inc. (0001477449) (Issuer)

      6/23/25 4:11:27 PM ET
      $TDOC
      Medical/Nursing Services
      Health Care
    • Director Anderson Kerrii B sold $130,000 worth of shares (500 units at $260.00), decreasing direct ownership by 4% to 12,666 units (SEC Form 4)

      4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

      6/12/25 10:07:20 AM ET
      $LH
      Medical Specialities
      Health Care

    $LH
    $TDOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

      Redburn Atlantic initiated coverage of Labcorp Holdings Inc. with a rating of Buy and set a new price target of $276.00

      4/2/25 8:50:29 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Holdings Inc. upgraded by Citigroup with a new price target

      Citigroup upgraded Labcorp Holdings Inc. from Neutral to Buy and set a new price target of $300.00 from $250.00 previously

      3/4/25 7:36:42 AM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Holdings Inc. upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Labcorp Holdings Inc. from In-line to Outperform and set a new price target of $265.00 from $260.00 previously

      1/7/25 8:12:52 AM ET
      $LH
      Medical Specialities
      Health Care

    $LH
    $TDOC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Labcorp to Announce Second Quarter Financial Results on July 24, 2025

      BURLINGTON, N.C., June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2025 before the market opens on Thursday, July 24, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The call will be webcast live on the Labcorp Investor Relations website. Participan

      6/26/25 4:10:00 PM ET
      $LH
      Medical Specialities
      Health Care
    • Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care

      New offering delivers convenient, comprehensive lab testing solutions for functional medicine, integrative medicine and primary care providers BURLINGTON, N.C., June 18, 2025 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp Whole Health Solutions to support the growing needs of functional medicine, integrative medicine and primary care providers in delivering holistic care. The solution launches specialized test panels and a tailored test menu of more than 1,000 scientifically backed biomarkers for cardiometabolic health, hormones, micronutrients, longevity and whole body wellness.

      6/18/25 7:00:00 AM ET
      $LH
      Medical Specialities
      Health Care
    • Teladoc Health to Participate in Upcoming Investor Conference

      NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations. About Teladoc HealthTeladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses propri

      6/5/25 8:00:36 AM ET
      $TDOC
      Medical/Nursing Services
      Health Care